Search Result "erenumab"
Optimal Dose of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Meta-Analysis
Journal: Current Neuropharmacology
Volume: 20 Issue: 2 Year: 2022 Page: 460-470
Author(s): Zhong Wang,Zhouqing Chen,Fan Jiang,Yue Sun,Da Wu,Mingjia Chen,Yanbo Yang
The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 19 Issue: 5 Year: 2020 Page: 344-359
Author(s): Abimael González-Hernández,Bruno A. Marichal-Cancino,Enrique GarcÃa-Boll,Carlos M. Villalón
New Therapeutic Options for Migraine
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 25 Year: 2023 Page: 1964-1966
Author(s): Maria Adele Giamberardino
Global Epidemiology, Clinical Features, Diagnosis and Current TherapeuticNovelties in Migraine Therapy and their Prevention: A Narrative Review
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3295-3311
Author(s):
Major Targets Involved in Clinical Management of Migraine
Journal: Current Neurovascular Research
Volume: 20 Issue: 3 Year: 2023 Page: 296-313
Author(s):
Novelty in Inflammation and Immunomodulation in Migraine
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 27 Year: 2019 Page: 2919-2936
Author(s): Cinzia Cavestro,Marcella Ferrero,Silvia Mandrino,Marco Di Tavi,Eugenia Rota
Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Journal: Current Drug Targets
Volume: 20 Issue: 5 Year: 2019 Page: 522-539
Author(s): Surovi Saikia,Manobjyoti Bordoloi,Rajeev Sarmah
A Complete Sojourn of Monoclonal Antibodies: AI, Rare Diseases / Disorders and Immunotoxic Effects
Journal: Current Proteomics
Volume: 21 Issue: 2 Year: 2024 Page: 58-78
Author(s):
SARS CoV-2 Omicron (B. 1.1. 529) Recent Updates and ChallengesWorldwide
Journal: Infectious Disorders - Drug Targets
Volume: 23 Issue: 5 Year: 2023 Page: 14-23
Author(s): Dinesh Kumar Mehta
Revolutionizing Neurological Disorder Treatment: Integrating Innovations inPharmaceutical Interventions and Advanced Therapeutic Technologies
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 19 Year: 2024 Page: 1459-1471
Author(s):